{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:29:44Z","timestamp":1795120184290,"version":"4.10.3"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.expneurol.2025.115545","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T23:41:12Z","timestamp":1762645272000},"page":"115545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Platelet-rich plasma intervention as a therapeutic agent versus L-DOPA in Parkinson's model induced by rotenone in male albino rats"],"prefix":"10.1016","volume":"396","author":[{"given":"Mona M.","family":"Elghareeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gehad E.","family":"Elshopakey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaymaa","family":"Rezk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Ateya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekramy M.","family":"Elmorsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala Magdy","family":"Anwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basma H.","family":"Marghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2025.115545_bb0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s40001-024-01779-7","article-title":"Role of GABA pathway in motor and non-motor symptoms in Parkinson\u2019s disease: a bidirectional circuit","volume":"29","author":"Alharbi","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.expneurol.2025.115545_bb0010","first-page":"110","article-title":"Pro-inflammatory, anti-inflammatory, and antioxidant activity of platelet rich plasma (PRP) on arthritic rats","volume":"13","author":"Al-Moussawi","year":"2022","journal-title":"J Nat Sc Biol Med"},{"key":"10.1016\/j.expneurol.2025.115545_bb0015","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s10787-022-01078-9","article-title":"Is sitagliptin effective for SARS-CoV-2 infection: false or true prophecy?","volume":"30","author":"Alomair","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.expneurol.2025.115545_bb0020","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s43440-023-00500-5","article-title":"DPP-4 inhibitors and type 2 diabetes mellitus in Parkinson\u2019s disease: a mutual relationship","volume":"75","author":"Alrouji","year":"2023","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.expneurol.2025.115545_bb0025","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1007\/s00415-012-6557-8","article-title":"The progression of non-motor symptoms in Parkinson\u2019s disease and their contribution to motor disability and quality of life","volume":"259","author":"Antonini","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.expneurol.2025.115545_bb0030","first-page":"2768","article-title":"Theories and practice of histological techniques","volume":"7","author":"Bancroft","year":"2013","journal-title":"New York, London and Madrid: Churchil Livingstone"},{"key":"10.1016\/j.expneurol.2025.115545_bb0035","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00192-019-03938-5","article-title":"Effect of the platelet-rich plasma covering of polypropylene mesh on oxidative stress, inflammation, and adhesions","volume":"31","author":"Belebecha","year":"2020","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.expneurol.2025.115545_bb0040","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115545_bb0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fnins.2016.00269","article-title":"Parkinson\u2019s disease and neurodegeneration: GABA-collapse hypothesis","volume":"10","author":"B\u0142aszczyk","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115545_bb0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","article-title":"Development of \u03b1-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson's disease","volume":"114","author":"Braak","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2025.115545_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fnsys.2021.682990","article-title":"Increasing serotonin to reduce parkinsonian tremor","volume":"15","author":"Caligiore","year":"2021","journal-title":"Front. Syst. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115545_bb0060","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.clinthera.2007.09.021","article-title":"Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson\u2019s disease","volume":"29","author":"Chen","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.expneurol.2025.115545_bb0065","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnins.2018.00252","article-title":"Therapeutic effect of platelet-rich plasma in rat spinal cord injuries","volume":"12","author":"Chen","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115545_bb0070","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.18632\/aging.101713","article-title":"Mechanistic insight into hyaluronic acid and platelet-rich plasma-mediated anti-inflammatory and anti-apoptotic activities in osteoarthritic mice","volume":"10","author":"Chiou","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.expneurol.2025.115545_bb0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1302\/2058-5241.6.200017","article-title":"Platelet-rich plasma: a narrative review","volume":"6","author":"Collins","year":"2021","journal-title":"EFORT Open Rev."},{"key":"10.1016\/j.expneurol.2025.115545_bb0080","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1093\/brain\/awad064","article-title":"Impaired dopamine release in Parkinson\u2019s disease","volume":"146","author":"Cramb","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2025.115545_bb0085","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1007\/s12035-018-1396-y","article-title":"Astrocytes and the TGF-\u03b21 pathway in the healthy and diseased brain: a double-edged sword","volume":"56","author":"Diniz","year":"2019","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2025.115545_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","article-title":"The Parkinson pandemic\u2014a call to action","volume":"75","author":"Dorsey","year":"2018","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.expneurol.2025.115545_bb0095","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1080\/19768354.2023.2273467","article-title":"Amelioration of rotenone-induced Parkinson\u2019s disease; comparing therapeutic role of erythropoietin versus low-level laser activation of mesenchymal stem cells (an in-vivo and in-vitro study)","volume":"27","author":"El Mahdy","year":"2023","journal-title":"Animal Cells and Systems"},{"key":"10.1016\/j.expneurol.2025.115545_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2020.111344","article-title":"The protective effect of biochanin A against rotenone-induced neurotoxicity in mice involves enhancing of PI3K\/Akt\/mTOR signaling and beclin-1 production","volume":"205","author":"El-Sherbeeny","year":"2020","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.expneurol.2025.115545_bb0105","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s12011-023-03792-z","article-title":"Effects of manganese and iron, alone or in combination, on apoptosis in BV2 cells","volume":"202","author":"Fang","year":"2024","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.expneurol.2025.115545_bb0110","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s10787-023-01305-x","article-title":"PI3K\/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson\u2019s disease in rats","volume":"32","author":"Farid","year":"2024","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.expneurol.2025.115545_bb0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-022-02496-w","article-title":"The role of toll-like receptors and neuroinflammation in Parkinson's disease","volume":"19","author":"Heidari","year":"2022","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2025.115545_bb0120","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s12035-022-03193-8","article-title":"Rotenone-induced model of Parkinson\u2019s disease: beyond mitochondrial complex I inhibition","volume":"60","author":"Ibarra-Guti\u00e9rrez","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2025.115545_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.prdoa.2023.100212","article-title":"Dopamine agonists in Parkinson\u2019s disease: impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment","volume":"9","author":"Isaacson","year":"2023","journal-title":"Clinical parkinsonism & related disorders"},{"key":"10.1016\/j.expneurol.2025.115545_bb0130","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1212\/WNL.58.suppl_1.S19","article-title":"Levodopa strengths and weaknesses","volume":"58","author":"Jankovic","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2025.115545_bb0135","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mds.29410","article-title":"Levodopa dose equivalency in Parkinson\u2019s disease: updated systematic review and proposals","volume":"38","author":"Jost","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2025.115545_bb0140","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/mds.28632","article-title":"Dopamine receptors in Parkinson\u2019s disease: a meta-analysis of imaging studies","volume":"36","author":"Kaasinen","year":"2021","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2025.115545_bb0145","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2025.115545_bb0150","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","article-title":"Decoding toll-like receptors: recent insights and perspectives in innate immunity","volume":"57","author":"Kawai","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.expneurol.2025.115545_bb0155","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fncel.2013.00053","article-title":"Interleukin-1\u03b2 and tumor necrosis factor-\u03b1: reliable targets for protective therapies in Parkinson\u2019s disease?","volume":"7","author":"Leal","year":"2013","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115545_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.967813","article-title":"Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson\u2019s disease rat model","volume":"16","author":"Magdy","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115545_bb0165","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/jcp.24909","article-title":"Human olfactory bulb neural stem cells mitigate movement disorders in a rat model of Parkinson\u2019s disease","volume":"230","author":"Marei","year":"2015","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.expneurol.2025.115545_bb0170","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.811843","article-title":"Preventive vitamin A supplementation improves striatal function in 6-hydroxydopamine hemiparkinsonian rats","volume":"9","author":"Marie","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.expneurol.2025.115545_bb0175","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/01.EHX.0000425981.52914.ca","article-title":"Chronic effect of aspartame versus stevioside on the cerebellar cortex of the adult albino rat: a histological and immunohistochemical study","volume":"36","author":"Mohamed","year":"2013","journal-title":"Egypt. J. Histol."},{"key":"10.1016\/j.expneurol.2025.115545_bb0180","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.mcn.2010.12.004","article-title":"Raised calcium promotes \u03b1-synuclein aggregate formation","volume":"46","author":"Nath","year":"2011","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115545_bb0185","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00018-022-04397-w","article-title":"Can the administration of platelet lysates to the brain help treat neurological disorders?","volume":"79","author":"Nebie","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.expneurol.2025.115545_bb0190","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s12951-024-02737-5","article-title":"Platelet-rich plasma-derived exosomes promote blood-spinal cord barrier repair and attenuate neuroinflammation after spinal cord injury","volume":"22","author":"Nie","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.expneurol.2025.115545_bb0195","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1902\/jop.2003.74.6.849","article-title":"Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-\u03b2 and modulates the proliferation of periodontally related cells in vitro","volume":"74","author":"Okuda","year":"2003","journal-title":"J. Periodontol."},{"key":"10.1016\/j.expneurol.2025.115545_bb0200","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/glia.20207","article-title":"Astrocyte activation and reactive gliosis","volume":"50","author":"Pekny","year":"2005","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2025.115545_bb0205","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1179\/014788802794791951","article-title":"Sensitivity of a novel biotin-free detection reagent (Powervision+\u2122) for immunohistochemistry","volume":"25","author":"Petrosyan","year":"2002","journal-title":"J. Histotechnol."},{"key":"10.1016\/j.expneurol.2025.115545_bb0210","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT\u2013PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.expneurol.2025.115545_bb0215","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.neurobiolaging.2016.11.015","article-title":"Effects of decreased dopamine transporter levels on nigrostriatal neurons and paraquat\/maneb toxicity in mice","volume":"51","author":"Richter","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.expneurol.2025.115545_bb0220","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1017\/cjn.2023.8","article-title":"Levodopa-induced dyskinesia in Parkinson\u2019s disease: plausible inflammatory and oxidative stress biomarkers","volume":"51","author":"Sarkar","year":"2024","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2025.115545_bb0225","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1523\/JNEUROSCI.23-34-10756.2003","article-title":"Mechanism of toxicity in rotenone models of Parkinson\u2019s disease","volume":"23","author":"Sherer","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115545_bb0230","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.736978","article-title":"Alpha-synuclein aggregation in Parkinson's disease","volume":"8","author":"Srinivasan","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.expneurol.2025.115545_bb0235","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neuropharm.2012.11.010","article-title":"L-DOPA-induced dopamine synthesis and oxidative stress in serotonergic cells","volume":"67","author":"Stansley","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2025.115545_bb0240","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1055\/s-0041-1726690","article-title":"Establishing the rotenone-induced Parkinson\u2019s disease animal model in Wistar albino rats","volume":"11","author":"Swamy","year":"2021","journal-title":"J. Health Alli. Sci. NU"},{"key":"10.1016\/j.expneurol.2025.115545_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e19452","article-title":"Therapeutic role of mesenchymal stem cells and platelet-rich plasma on skin burn healing and rejuvenation: A focus on scar regulation, oxido-inflammatory stress and apoptotic mechanisms","volume":"9","author":"Tammam","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/j.expneurol.2025.115545_bb0250","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1523\/JNEUROSCI.2952-16.2017","article-title":"Deficiency in neuronal TGF-\u03b2 signaling leads to nigrostriatal degeneration and activation of TGF-\u03b2 signaling protects against MPTP neurotoxicity in mice","volume":"37","author":"Tesseur","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115545_bb0255","article-title":"Chemically induced models of Parkinson's disease","volume":"252","author":"Thirugnanam","year":"2022","journal-title":"Comp. Biochem. Physiol., Part C: Toxicol. Pharmacol."},{"key":"10.1016\/j.expneurol.2025.115545_bb0260","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1002\/jnr.10614","article-title":"EGF and NGF injected into the brain of old mice enhance BDNF and ChAT in proliferating subventricular zone","volume":"72","author":"Tirassa","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2025.115545_bb0265","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/iwj.13602","article-title":"Rational selection of bioactive principles for wound healing applications: growth factors and antioxidants","volume":"19","author":"Via\u00f1a-Mendieta","year":"2022","journal-title":"Int. Wound J."},{"key":"10.1016\/j.expneurol.2025.115545_bb0270","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1007\/s12035-022-02978-1","article-title":"GDNF promotes astrocyte abnormal proliferation and migration through the GFR\u03b11\/RET\/MAPK\/pCREB\/LOXL2 signaling axis","volume":"59","author":"Wang","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.expneurol.2025.115545_bb0275","doi-asserted-by":"crossref","first-page":"375","DOI":"10.4103\/1673-5374.346461","article-title":"Platelet-rich plasma promotes peripheral nerve regeneration after sciatic nerve injury","volume":"18","author":"Wang","year":"2023","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.expneurol.2025.115545_bb0280","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.reth.2024.03.017","article-title":"Platelet-rich plasma (PRP) in nerve repair","volume":"27","author":"Wang","year":"2024","journal-title":"Regenerative Therapy"},{"key":"10.1016\/j.expneurol.2025.115545_bb0285","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1046\/j.0953-816x.2001.01743.x","article-title":"Persistent changes in striatal gene expression induced by long-term L-DOPA treatment in a rat model of Parkinson\u2019s disease","volume":"14","author":"Westin","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.expneurol.2025.115545_bb0290","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00018-022-04574-x","article-title":"The role of tyrosine hydroxylase\u2013dopamine pathway in Parkinson\u2019s disease pathogenesis","volume":"79","author":"Zhou","year":"2022","journal-title":"Cell. Mol. Life Sci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625004108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488625004108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:57:11Z","timestamp":1781006231000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488625004108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":58,"alternative-id":["S0014488625004108"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115545","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Platelet-rich plasma intervention as a therapeutic agent versus L-DOPA in Parkinson's model induced by rotenone in male albino rats","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2025.115545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115545"}}